MOLN Molecular Partners AG
$3.71▼ -2.60%
Healthcare
Other
Volume 1.8K
Avg Volume (10D) 2.2K
Key Metrics & Fundamentals
Market Cap
$142.15M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.52 - 5.36
% vs 50 MA
-8.06%
% vs 200 MA
-11.16%
RSI-14
45.4
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.34
Free Cash Flow
-$10.81M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$13.07M
COGS
–
Operating Exp
$13.59M
Operating Income
-$13.59M
EBIT
-$13.59M
Pretax Income
-$13.56M
Net Income
-$13.56M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News
Molecular Partners Nominates MP0730 as Next Candidate in Expanding Pipeline of Radiotherapeutics, Targeting CD70
GlobeNewswire · Oct 22, 2026 1:00 AM ET
Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study
GlobeNewswire · Aug 25, 2026 1:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MOLN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.